Methods and dosage forms for the treatment of human cancers

Abstract

Methods for the treatment of human cancers, daily dosage forms for cancer patients, and methods of formulating the dosage forms are provided wherein the daily dosage form contains from about 10-6,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. Preferably, the dosage forms are formulated by first creating an aqueous decoction of Arum palaestinum Boiss, followed by fortification of the decoction with additional quantities of β-sitosterol, isovanillin, and linolenic acid.

1 . A method for the treatment of human cancers comprising the step of administering to a cancer patient a dosage form containing from about 10-6,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. 
     
     
         2 . The method of  claim 1 , said dosage form containing from about 1,000-4,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. 
     
     
         3 . The method of  claim 2 , said dosage form containing from about 2,500-3,500 mg of each of β-sitosterol, isovanillin, and linolenic acid. 
     
     
         4 . The method of  claim 2 , including the step of administering said dosage form on a daily basis. 
     
     
         5 . The method of  claim 1 , said dosage form selected from the group consisting of an aqueous dispersion, capsule, pill, and tablet. 
     
     
         6 . The method of  claim 5 , said dosage form being an aqueous dispersion. 
     
     
         7 . The method of  claim 6 , said aqueous dispersion comprising a decoction made using plant parts of  Arum palaestinum  Boiss. 
     
     
         8 . The method of  claim 7 , said aqueous dispersion further including additional amounts of β-sitosterol, isovanillin, and linolenic acid not derived from said decoction. 
     
     
         9 . The method of  claim 5 , said dosage form being a capsule containing lypholized solids derived from a decoction made using plant parts of  Arum palaestinum  Boiss. 
     
     
         10 . The method of  claim 9 , said lypholized solids further including additional amounts of β-sitosterol, isovanillin, and linolenic acid not derived from said decoction. 
     
     
         11 . A human cancer treatment comprising a daily dosage form containing from about 10-6,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. 
     
     
         12 . The treatment of  claim 11 , said dosage form containing from about 1,000-4,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. 
     
     
         13 . The treatment of  claim 12 , said dosage form containing from about 2,500-3,500 mg of each of β-sitosterol, isovanillin, and linolenic acid. 
     
     
         14 . The treatment of  claim 12 , including the step of administering said dosage form on a daily basis. 
     
     
         15 . The treatment of  claim 11 , said dosage form selected from the group consisting of an aqueous dispersion, capsule, pill, and tablet. 
     
     
         16 . The treatment of  claim 15 , said dosage form being an aqueous dispersion. 
     
     
         17 . The treatment of  claim 16 , said aqueous dispersion comprising a decoction made using plant parts of  Arum palaestinum  Boiss. 
     
     
         18 . The treatment of  claim 17 , said aqueous dispersion further including additional amounts of β-sitosterol, isovanillin, and linolenic acid not derived from said decoction. 
     
     
         19 . The treatment of  claim 15 , said dosage form being a capsule containing lypholized solids derived from a decoction made using plant parts of  Arum palaestinum  Boiss. 
     
     
         20 . The treatment of  claim 19 , said lypholized solids further including additional amounts of β-sitosterol, isovanillin, and linolenic acid not derived from said decoction. 
     
     
         21 . A method of formulating a daily dosage form for the treatment of human cancers comprising the steps of:
 creating an aqueous decoction of  Arum palaestinum  Boiss; and   fortifying said decoction by adding thereto amounts of β-sitosterol, isovanillin, and linolenic acid not derived from said decoction such that total quantities of β-sitosterol, isovanillin, and linolenic acid are each from about 10-6,000 mg.   
     
     
         22 . The method of  claim 21 , said dosage form containing from about 1,000-4,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. 
     
     
         23 . The method of  claim 22 , said dosage form containing from about 2,500-3,500 mg of each of β-sitosterol, isovanillin, and linolenic acid. 
     
     
         24 . The method of  claim 21 , said dosage form being said fortified aqueous decoction. 
     
     
         25 . The method of  claim 21 , including the step of lypholizing said fortified aqueous decoction to create lypholized decoction solids. 
     
     
         26 . The method of  claim 25 , including the step of placing said solids in a capsule to create said dosage form. 
     
     
         27 . The method of  claim 25 , including the step of tableting said solids to create a tablet or pill dosage form. 
     
     
         28 . The method of  claim 21 , said decoction-creating step comprising the steps of:
 comminuting plant parts of  Arum palaestinum  Boiss;   placing said comminuted plant parts in water to form a mixture;   boiling the mixture for a period of time; and   allowing the mixture to cool.   
     
     
         29 . The method of  claim 28 , said plant parts comprising from about 12-18 grams of leaves and from about 12-18 grams of root, said mixture comprising said leaves and root in about one gallon of water. 
     
     
         30 . The method of  claim 28 , including the step of boiling said mixture for a period of from about 10-15 minutes.